Granules India announced that the US FDA has completed inspection of the facility of Granules Pharmaceuticals, Inc., a whollyowned foreign subsidiary of the Company located in Chantilly, Virginia, USA on 21 August 2019 with two (2) minor observations.
This is a pre-approval inspection for seven products filed from this facility. Granules Pharmaceuticals, Inc. will respond to these observations within the stipulated time period.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)